![Jules S. Jacob](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jules S. Jacob
Corporate Officer/Principal bei
ACTAVIA LIFE SCIENCES, INC.
Profil
Jules S.
Jacob was the founder of Spherics, Inc. (founded in 1997) where he held the title of Director-Research & Development from 1997 to 2010.
He is currently working as a Senior Director-CMC & Non-Clinical Development at Actavia Life Sciences, Inc. since 2017 and is also a Member of the American Association of Pharmaceutical Scientists.
Mr. Jacob previously worked as a Senior Director-Product Development at Aprecia Pharmaceuticals Co. from 2009 to 2017, as a Director-Formulation Development at Panacos Pharmaceuticals, Inc. from 2007 to 2008, and as an Executive Director-CMC & Non Clinical Development at Tiziana Life Sciences Ltd. (United Kingdom) from 2022 to 2024.
Mr. Jacob completed his undergraduate and graduate degrees at Brown University.
Aktive Positionen von Jules S. Jacob
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Corporate Officer/Principal | 01.07.2017 |
American Association of Pharmaceutical Scientists
 American Association of Pharmaceutical Scientists BiotechnologyHealth Technology Engages in research and development of pharmaceutical products | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jules S. Jacob
| Unternehmen | Position | Ende |
|---|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Corporate Officer/Principal | 30.04.2024 |
Aprecia Pharmaceuticals Co.
 Aprecia Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs | Corporate Officer/Principal | 01.07.2017 |
Spherics, Inc.
 Spherics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Gründer | 07.01.2010 |
| PANACOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.12.2008 |
Ausbildung von Jules S. Jacob
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Spherics, Inc.
Spherics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Aprecia Pharmaceuticals Co.
Aprecia Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panacos Pharmaceuticals, Inc.
 Panacos Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology Engages in research and development of pharmaceutical products | Health Technology |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Health Technology |
Actavia Life Sciences, Inc.
 Actavia Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
